|
Specifics about each Level and each Item:
What you do you need to know:
Level 2
• Diagnose and management of
common systemic diseases
a.
Neurologic complications of ETOH abuse
1.
Withdrawal seizures
2. Encephalopathy (Wernicke syndrome)
3. The role of vitamins, glucose, etc. in treatment
4. Associated disorders: meningitis, head trauma
5. Delirium tremens
b.
Neurologic complications of diabetes mellitus
1.
Hypoglycemia, hyperglycemia in an ER setting
2. Polyneuropathy, mononeuropathy – initial treatment of
pain of polyneuropathy
c. Basic
complications of renal failure
d. Neurologic manifestations of drug overdose in the ER
setting, particularly cocaine and heroin
e. Syncope versus epileptic seizures (witnessed and
unwitnessed)
Level 3
• Diagnosis and management of
uncommon manifestations of hyperglycemia (nonketotic
hyperglycemic states)
a. Focal
seizures including focal status and other focal motor
activity
b. Hemiparesis
• Diagnosis and management of
common rheumatologic disorders
a.
Polymyalgia rheumatica/temporal arteritis
b. SLE: meningeal complication, cerebritis, symptoms
such as headache and epilepsy.
c. Antiphospholipid syndrome
• Diagnosis and management of
unusual PNS syndromes secondary to diabetes mellitus
a.
Cranial mononeuropathies, particularly III, IV, VI
b. Diabetic amyotrophy, polyradiculopathy
c. Limb mononeuropathies
d. Dysautonomias
• Diagnosis and manage the
neurological complications of sarcoid
• Diagnosis and management of B12
deficiencies
Level 4
• Diagnosis and management of the
neurologic manifestations of endocrine disorders
a. Thyroid disease
1.
Hyperthyroidism: tremor, Graves ophthalmopathy,
cognitive changes, myopathy
2. Hypothyroidism: mental changes, myopathy
b.
Parathyroid disorders
c. Adrenal gland disorders: pheochromocytoma
d. Pituitary disease
• Diagnosis and management of
unusual connective tissue disorders
a.
Behcet’s disease
b. Polyarteritis nodosa
• Diagnosis and treatment of the
neurologic manifestations of proliferative hematologic
disorders
a. Plasma
cell dyscrasias
b. Lymphomas
c. CNS and PNS involvement
|
